February is about to end on a sweet note for income investors, with close to 70 S & P 500 companies expected to announce dividend hikes...
An employee works on the production line of pharmaceutical company Zentiva in Prague, Czech Republic, May 6, 2021. David W. Cerny | Reuters The health-care sector...
This year’s powerful rally has more than made up for the carnage of 2022 on Wall Street. Tech stocks reasserted their leadership and even some out-of-favor...
Much of the gains in the S & P 500 this year can be attributed to the “Magnificent Seven” stocks. The group comprises Apple , Amazon...
In 2023 true diversification killed you. If you chose to buy stocks across a wide swath of sectors —financials, retailers, drugs, foods, utilities, autos, airlines and...
CNBC’s Jim Cramer on Friday provided insight into next week’s Wall Street happenings. He said he’ll be paying close attention to several quarterly earnings reports, especially...
First-quarter earnings season is about to kick off, and investors should be prepared to be inundated with endless headlines, news stories and analyses — some more...
January’s market rally faces a major test in the week ahead from multiple major events, the most important of which could be the Federal Reserve’s interest...
September has historically been a seasonally weak month for stocks, and the market’s performance over the past month has certainly burnished that reputation. Hawkish comments from...
Republican Pennsylvania Senate candidate Dr. Mehmet Oz has financial ties to at least two pharmaceutical companies that supply hydroxychloroquine, an anti-malaria drug that he has floated...
